Eli Lilly said Friday that it has applied for U.S. regulatory approval to expand the use of its weight-loss drug Zepbound to include treatment of sleep apnea, as new data show the drug may help many people breathe easier at night.
Investors poured money into technology funds at a record pace over the past week, as surging demand for artificial-intelligence winners like Nvidia helped the chip designer briefly eclipse Microsoft as the world’s most valuable company.
The Federal Reserve may increase stress capital buffers at Truist Financial Corp. and KeyCorp and ease them for Goldman Sachs Group Inc., Citigroup Inc. and other big banks when the central bank releases stress-test results Thursday, analysts at KBW...
This analyst is recommending buying the bonds given the company’s huge free cash flow and minimal leverage.
A Wolfe analyst doesn’t think next week’s earnings report will prove a “meaningful catalyst” for Micron shares. He’s more enthused about earnings power over the medium term.
Aggregate retail-investor portfolios are beating market benchmarks like the S&P 500 this year and closely trailing the Nasdaq, according to data from Vanda Research.
Rising tensions in the Middle East following an Israeli military attack on Hezbollah targets in southern Lebanon are bound to raise concerns about crude supplies in the region, yet failed to contribute to a rise in oil prices on Friday.
Also: How to broaden your exposure to semiconductor stocks, help with retirement planning, and a complex financial crime.
